Copyright Notice
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Bookshelf ID: NBK563396PMID: 33104319
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 1703793-34-3
Drug Levels and Effects
Summary of Use during Lactation
No information is available on the clinical use of avapritinib during breastfeeding. Because avapritinib is 98.8% bound to plasma proteins, the amounts in milk are likely to be low. However, the manufacturer recommends avoiding breastfeeding during therapy and for 2 weeks following the final dose.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Avapritinib
CAS Registry Number
1703793-34-3
Drug Class
Breast Feeding
Antineoplastic Agents
Enzyme Inhibitors
Protein Kinase Inhibitors
Signal Transduction Inhibitors
Tyrosine Kinase Inhibitors
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- Review Pralsetinib.[Drugs and Lactation Database (...]Review Pralsetinib.. Drugs and Lactation Database (LactMed®). 2006
- Review Ruxolitinib.[Drugs and Lactation Database (...]Review Ruxolitinib.. Drugs and Lactation Database (LactMed®). 2006
- Review Venetoclax.[Drugs and Lactation Database (...]Review Venetoclax.. Drugs and Lactation Database (LactMed®). 2006
- Review Olaparib.[Drugs and Lactation Database (...]Review Olaparib.. Drugs and Lactation Database (LactMed®). 2006
- Review Vemurafenib.[Drugs and Lactation Database (...]Review Vemurafenib.. Drugs and Lactation Database (LactMed®). 2006
- Avapritinib - Drugs and Lactation Database (LactMed®)Avapritinib - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...